» Articles » PMID: 39277713

Hypoparathyroidism After Total Thyroidectomy: Reactive to Symptoms Supplementation

Overview
Journal BMC Surg
Publisher Biomed Central
Specialty General Surgery
Date 2024 Sep 14
PMID 39277713
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: After total thyroidectomy (TT), postoperative hypoparathyroidism (PH) is the most frequent complication. Yet, management strategies for PH remain disputed. The aim of this study was to evaluate outcomes of a reactive supplementation in case of symptomatic PH. Additionally, risk factors for symptomatic PH and readmission due to PH were analyzed.

Materials And Methods: All consecutive patients who underwent TT or completion from 2017 to 2022 were considered for inclusion. During this period, a reactive to symptom vitamin-calcium supplementation was used. The primary outcome was the occurrence of severe PH after discharge resulting in readmission.

Results: Overall, 307 patients were included, of which 98 patients (31.9%) developed symptomatic PH including 43 patients before discharge. Independent risk factors for developing symptomatic PH were age (p = 0.010) and postoperative day 1 (POD1) PTH level (p < 0.001). Overall, 264 patients (86%) did not present PH before discharge and were discharged home. Among them, 55 patients (20.8%) experienced symptomatic PH, requiring readmission in 18 patients. The overall readmission rate owing to symptomatic PH requiring intravenous supplementation despite oral vitamin-calcium supplementation was 6.8% (n = 18). Independent risk factors for symptomatic PH-related readmission were age (p = 0.007) and POD1 PTH level (p < 0.001). Adequate cut-off values for predicting readmission were POD1 albumin-adjusted calcium = 2.1 mmol/l (Sensibility = 0.95, Specificity = 0.30) and POD1 PTH = 11.5 pg/ml (Sensibility = 0.90, Specificity = 0.71).

Conclusion: Supplementing only symptomatic patients was safe and efficient. This attitude does not alter on morbidity, mortality or readmission rate which is in line with current literature.

References
1.
Lorente-Poch L, Sancho J, Munoz-Nova J, Sanchez-Velazquez P, Sitges-Serra A . Defining the syndromes of parathyroid failure after total thyroidectomy. Gland Surg. 2015; 4(1):82-90. PMC: 4321048. DOI: 10.3978/j.issn.2227-684X.2014.12.04. View

2.
Wang Y, Bhandari A, Yang F, Zhang W, Xue L, Liu H . Risk factors for hypocalcemia and hypoparathyroidism following thyroidectomy: a retrospective Chinese population study. Cancer Manag Res. 2017; 9:627-635. PMC: 5697449. DOI: 10.2147/CMAR.S148090. View

3.
Balasubramanian S . Iatrogenic/post-surgical hypoparathyroidism: where do we go from here?. Endocrine. 2014; 47(2):357-9. DOI: 10.1007/s12020-014-0397-5. View

4.
Nagel K, Hendricks A, Lenschow C, Meir M, Hahner S, Fassnacht M . Definition and diagnosis of postsurgical hypoparathyroidism after thyroid surgery: meta-analysis. BJS Open. 2022; 6(5). PMC: 9437325. DOI: 10.1093/bjsopen/zrac102. View

5.
Di Lorenzo S, Carrillo Lizarazo J, Dionigi G, Kraimps J, Donatini G . Impact of near-infrared fluorescence imaging plus indocyanine green fluorescence on postoperative hypoparathyroidism rates after total thyroidectomy and central neck lymph node dissection. Br J Surg. 2024; 111(2). DOI: 10.1093/bjs/znae022. View